Metastasis and Tumor Progression, Neoplasia of Endocrine Tissue, Therapies for Cancer, and Tumorigenesis (posters) (posters)

SUN 060

Aggressive Pheochromocytomas and Paragangliomas: Clinicopathologic Spectrum Emphasizing Treatment Dilemmas
Iuri Martin Goemann, Thiza Massaia Londero, Ana Marina da Silva Moreira, Gustavo Cipriani, Camila Viecceli, Sheila Piccoli Garcia and Mauro Antonio Czepielewski

SUN 061

Acute-Onset Psychosis As a Presenting Symptom of Pheochromocytoma
Ari Geliebter, Stephanie Charles, Jose Nahun Galeas, Jay S Meisner, Norman Fleischer and Ulrich K Schubart

SUN 062

Doege-Potter Syndrome: A Diagnostic Challenge
Anardi Augusto Agosto Mujica, Karol Sanchez and Marielba Agosto Mujica

SUN 063

Exploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in the Follow-up of Patients with Neuroendocrine Tumors
Franco Grimaldi, Cecilia Motta, Claudia Cipri, Veronica Tonelli, Cinzia Pistis, Elio Tonutti, Francesco Curcio, Martina Fabris and Fabio Vescini

SUN 064

Long-Term Outcomes in Patients with Men-1 and Pancreaticoduodenal Neuroendocrine Tumors
Diane Donegan, Naykky Maruquel Singh Ospina, Rene Rodriguez-Gutierrez, Zahraa Al-Hilli, Geoffrey B Thompson, Bart Lyman Clarke and William F. Young Jr.

SUN 065

YY1 Mutations Are Absent in Non-Functioning Pancreatic Neuroendocrine Tumors
Johan Kugelberg, Tobias Akerstrom, Rajani Maharjan, Per Hellman and Peyman Bjorklund

SUN 066

Loss of Expression of Atrx Is a Frequent Event in Pancreatic Neuroendocrine Tumors
Philip Göstasson, Birgitta Bondeson, Peyman Bjorklund and Per Hellman

SUN 067

Detection of Duodenal and Pancreatic Neuroendocrine Tumors in MEN1 Patients: Comparison of the Performance of [68ga]-DOTA-TOC PET/CT and [111in]-DTPA-Pentetreotide
Fritz-Line Velayoudom-Cephise, Clément Morgat, Paul Schwartz, Marie Laure Nunes, Martine Guyot, Jurgen Schulz, Joachim Mazère, Delphine Gaye, Denis Smith, Elif Hindié, Philippe Fernandez and Antoine Tabarin

SUN 068

Expanded Analysis of Variants of Unknown Significance of RET Gene
Rodrigo de Almeida Almeida, Roxanne Hatanaka, Delmar Muniz Lourenco Jr., Tomoko Sekiya and Sergio P A Toledo

SUN 069

Comparison of 68ga-Dotatate PET/CT with 111in-Octreotide Scintigraphy in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Results from a Large, Single-Center Prospective Cohort
Daniel Soares Freire, George B Coura, Ricardo Miguel Costa de Freitas, Rachel Riechelmann, Delmar M. Lourenco Junior, Maria Adelaide Albergaria Pereira, Tulio Eduardo Flesch Pfiffer, Maria Candida Barisson Villares Fragoso, Carlos Buchpigel, Carlos Buchpigel and Ana O Hoff

SUN 070

SST2 Effects in Pancreatic Neuroendocrine Tumors Are Mediated By Filamin-a
Andrea G Lania, Eleonora Vitali, Valeria Cambiaghi, Carlo Carnaghi, Alessandro Zerbi, Piergiuseppe Colombo, Erika Peverelli, Anna Spada and Giovanna Mantovani

SUN 071

Screening to MEN1 in Relatives Under-Risk of Disease: Concordance Between Clinical and Laboratory Evaluation
Michele Renata de Souza, Carlos Henrique Alencar, Manoel Ricardo Alves Martins, Eveline Gadelha Pereira Fontenele, Maria Elisabete Amaral de Moraes, Manoel Odorico de Moraes Filho and Ana Rosa Quidute

SUN 072

Molecular Insights into Men-1 Phenocopies
Ekaterina A Pigarova, Elizaveta O Mamedova, Elena G Przhiyalkovskaya, Larisa K Dzeranova, Liudmila Ya Rozhinskaya, Natalia G Mokrysheva and Anatoly N Tiulpakov

SUN 073

Next-Generation Sequencing: Validating Desktop Sequencer As a Cost-Effective Tool to Genetic Screening of Multiple Endocrine Neoplasia Type 1 Index Cases
Rafael Arrabaça Carvalho, Alexander Augusto Lima Jorge, Antonio M Lerario, Sehiya Tomoko, Viviane C Longuini, Elisangela Pereira de Souza Quedas, Michelle B Moraes, Lucas Santos Santana, Betsaida Urtremari, Sueli Mieko Oba Shinjo, Suely Kazue Nagahashi Marie, Sergio P A Toledo, Rodrigo A Toledo and Delmar Muniz Lourenco Jr.

SUN 074

Psychological Harm and Quality of Life  in Patients with Multiple Endocrine Neoplasia Type 2
Karine Cândido Rodrigues, Rodrigo A Toledo, Flavia Lima Coutinho, Ana O Hoff, Sergio P A Toledo and Delmar Muniz Lourenco Jr.

SUN 075

Loss-of-Function Germline FGFR1 mutation Identified in a Patient with Prolactinoma
Mark J McCabe, Anthony Lam, Tanya Thompson, Marcel E Dinger and Ann I McCormack

SUN 076

The TMEM127 Tumor Suppressor Is a Component of the Lysosomal mTOR Activation Complex and Modulates Autophagy
Yilun Deng, Yuejuan Qin, Subramanya Srikantan, Anqi Luo, Exing Wang and Patricia L Dahia

SUN 078

Characteristics and Patterns of Metastatic Disease from Chordoma
Kevin Matthew Curtis, Victoria A Young, H. Thomas Temple, Frank J Eismont, Thomas F DeLaney and Francis J Hornicek

SUN 079

EGFR and IGF1R Regulate Cell Viability and Response to Treatment in Bronchopulmonary Neuroendocrine Tumors
Teresa Gagliano, Erica Gentilin, Katiuscia Benfini, Simona Falletta, Marco Schiavon, Carmelina Di Pasquale, Narciso Giorgio Cavallesco, Eleonora Riva, Federico Rea, Ettore Ciro degli Uberti and Maria Chiara Zatelli

SUN 080

Analysis of Common and Uncommon Tumors Associated with Multiple Endocrine Neoplasia Types 1 and 2 from a Developing Registry
Karen Joanie Campoverde Reyes, Charu Baskaran, Vibha Singhal and Madhusmita Misra

SUN 081

Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study
Esther N. Klein Hesselink, Adrienne H. Brouwers, Johan R de Jong, Anouk N A Van der Horst-Schrivers, Rob P. Coppes, Joop D. Lefrandt, Piet L. Jager, Arjan Vissink and Thera P Links

SUN 082

Diffuse Micronodular Metastases Predicts Better Survival in Patients with Lung Metastasis of Papillary Thyroid Carcinoma
Mijin Kim, Won Gu Kim, Su-yeon Park, Hyemi Kwon, Min Ji Jeon, Jong Jin Lee, Jin-Sook Ryu, Tae Yong Kim, Young Kee Shong and Won Bae Kim

SUN 083

the Role of Reactive Oxygen Species Production in Activation of Innate Adjuvant Receptor Signals in Thyroid Carcinoma
Dong Yeob Shin, Jiyean An, Sena Hwang, Young Suk Jo, Eun Seok Kang, Woong Youn Chung and Eun Jig Lee

SUN 084

SUN 086

Chronic Exposure to EPI-002 May Select for Drug Resistant Clones in Prostate Cancer Via an EPI-Specific Mechanism
Jon K. Obst, Yu Chi Yang, Jun Wang, Amy H Tien, Gang Wang, Nasrin R Mawji and Marianne D Sadar

SUN 087

Dissociation of a Camptothecin Analog NSC606985 Induced Unconventional ER-Stress and Cell Death in DU145 Prostate Cancer Cells
Liping Wang, Pengcheng Fu, Yuan Zhao, Guo Wang, Richard Yu, Xin Wang, Julianne Imperato-McGinley and Yuan-Shan Zhu

SUN 089

Associations of Thyroid Hormones with Incident Prostate, Colorectal and Lung Cancer in the Health in Men Study (HIMS)
Yi Xian Chan, Helman Alfonso, Paul Chubb, Jonathan Golledge, Leon Flicker and Bu Beng Yeap

SUN 090

Selective Androgen Receptor Modulator, S42 Suppresses Cell Proliferation of Prostate Cancer Cells
Takako Kawanami, Tomoko Tanaka, Takashi Nomiyama and Toshihiko Yanase

SUN 091

Targeting the Long Non-Coding RNA Ghsros, a Mediator of Prostate Cancer Tumour Growth, with Short Antisense Oligonucleotides
Patrick B. Thomas, Carina M. Walpole, Penny L. Jeffery, Lidija Jovanovic, Adrian C. Herington, Colleen C. Nelson, Eliza J. Whiteside, Rakesh N. Veedu, Inge Seim and Lisa K. Chopin

SUN 092

Micrornas Mediate Anti-Tumor Effects in Castration-Resistant Prostate Cancer
Sarah Quynh Giao To, Pheruza Tarapore, Bin Ouyang, Yuet-Kin Leung, Ana Cheong and Shuk-Mei Ho

SUN 093

An ERα Biomodulator Hyperactivates the Unfolded Protein Response, Inactivates MDR1 and Restores Sensitivity of Ovarian Cancer Cells to Taxanes
Xiaobin Zheng, Neal D Andruska, Michael Lambrecht, Sisi He, Erik Russell Nelson, Paul Hergenrother and David J Shapiro

SUN 094

Oocyte-Driven Granulosa Cell Tumorigenesis in Mouse Ovary
So-Youn Kim, Katherine Ebbert, Marilia Cordeiro, Megan Romero, Kelly A Whelan, Teresa K Woodruff, Adrian Suarez and Takeshi Kurita

SUN 096

Role of Increased Mir-29b-1 and Mir-29a in Endocrine-Resistant Breast Cancer
Penn Muluhngwi, Joshua T Napier and Carolyn M Klinge

SUN 097

A Potential Role of Endogenous SERM, 27-Hydroxy Cholesterol Synthesizing Enzyme, CYP27A1 in Breast Tumor Microenvironment
Minako Sakurai, Yasuhiro Miki, Kiyoshi Takagi, Takashi Suzuki and Hironobu Sasano

SUN 098

C-Src Regulates the Activation of Novel Estrogen Signaling Pathway and Is Related to Breast Cancer Cell Migration
Javier Esteban Jimenez-Salazar, Rosa Isela Garcia-Vázquez, Jonathan González-Ruiz, Carlos Lara-Cruz and Pablo Damian-Matsumura

SUN 099

Tumor Suppressor Mir-16 Mediates ErbB-2-Targeted Therapies Effects in Breast and Gastric Cancer
Leandro Venturutti, Rosalia Ines Cordo Russo, Martín Alfredo Rivas, Florencia Mercogliano, Franco Izzo, Mara De Martino, Robert H Oakley, Patricio Yankilevich, Daniel Allemand, Eduardo Hernán Charreau, John A Cidlowski, Roxana Schillaci and Patricia Virginia Elizalde

SUN 100

Combined Effects of Blocking Estrogen Receptors and Inhibiting HER-2 Converges on Wnt/Beta-Catenin Pathway in the Human Breast Cancer Cell Line T47D
Javier Esteban Jimenez-Salazar, Tzitzijanik Madrigal-Domínguez, Marcela Arteaga-Silva, Claudia Haydée González-De la Rosa and Pablo Damian-Matsumura

SUN 102

Silencing the LDLR in Breast Cancer Cells Leads to Decreased Growth of Tumor Xenografts in a Mouse Model of Hyperlipidemia
Zara Zelenko, Derek LeRoith, Irini Markella Antoniou, Laya Rajan and Emily Jane Gallagher

SUN 103

TNFα Induces Resistance to Trastuzumab By Upregulation of Mucin 4 in HER2-Positive Breast Cancer
Marí­a Florencia Mercogliano, Mara De Martino, Leandro Venturutti, Martín Alfredo Rivas, Gloria Inurrigarro, Cecilia Jazmín Proietti, Isabel Frahm, Daniel Allemand, Ernesto Gil Deza, Sandra Ares, Felipe Gustavo Gercovich, Patricia Virginia Elizalde and Roxana Schillaci

SUN 104

Natural Phenolic Compound Honokiol Inhibits Leptin-Induced Epithelial to Mesenchymal Transition in Breast Cancer
Dimiter Bogdanov Avtanski, Arumugam Nagalingam, Panjamurthy Kuppusamy, Neeraj K Saxena and Dipali Sharma